Success Stories: EB-1A Approved for Scientist in New York in the Field of Pharmaceutical Sciences

Client’s Testimonial:

I highly appreciate the outstanding work and help provided by North America Immigration Law group to me during my I-140 petition. They have very good understanding of the case and even easily understood my research and full profile to make the petition. There response before committed time is really appreciable. I found that the case taken by them is a big assurance that it is going to be approved. My EB1A– I-140 got approved very quickly even the day after the premium processing application was received without any RFE or difficulty. I highly recommend Chen Immigration Team for green card petitions. Thanks a lot for their big help.I highly appreciate the outstanding work and help provided by North America Immigration Law group to me during my I-140 petition. They have very good understanding of the case and even easily understood my research and full profile to make the petition. There response before committed time is really appreciable. I found that the case taken by them is a big assurance that it is going to be approved. My EB1A– I-140 got approved very quickly even the day after the premium processing application was received without any RFE or difficulty. I highly recommend Chen Immigration Team for green card petitions. Thanks a lot for their big help.

On October 17^th, 2014, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Scientist in the Field of Pharmaceutical Sciences (Approval Notice)

General Field: Pharmaceutical Sciences

Position at the Time of Case Filing: Scientist

Country of Origin: India

State of Residence at the Time of Filing: New York

Approval Notice Date: October 17^th, 2014

Processing Time: 18 Days (4 Days After Premium Processing Requested)

Case Summary:

For this case we were granted the opportunity to work with a pharmaceutical scientist from India, whose research focused on the design, synthesis, and characterization of inhibitors involved in multi-drug resistance to anticancer therapeutics. He had published a prolific 25 peer-reviewed scientific articles, as well as given numerous presentations at conferences both national and international; furthermore, his work had been cited no fewer than 279 times at case filing, by independent and leading researchers worldwide working at prestigious institutions and for prominent organizations, indicating its major significance. He had also reviewed 13 manuscripts for distinctive, internationally-circulated journals. An independent recommender affirmed our client’s superior expertise: “His research specifically targets the problem of multi-drug resistance (MDR), a process…by which anticancer drugs are eliminated from cancer cells in cancer patients, rendering cancer chemotherapy ineffective…I can recommend [Client] as a very successful pharmaceutical scientist who is an eminent investigator in the field of multidrug resistance, with the goal of developing new strategies for successfully treating cancer.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Pharmaceutical Sciences, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in eighteen days.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.